Edit |   |
---|---|
Antigenic Specificity | CA9, Human (Girentuximab biosimilar) |
Clone | Girentuximab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | WB, FuncS, IF, Neut, ELISA, FCM, IP, PK, IHC, Activ |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CA9 Recombinant Antibody. Girentuximab (trade name Rencarex) is a chimeric IgG1 monoclonal antibody to carbonic anhydrase IX (CAIX). CAIX is expressed on the surface of most renal cancer cells and is hypothesized to be on the surface of other tumor cells. It is investigational agent in clinical trials for renal cell carcinoma. Its development was suspended as a "naked" or unconjugated antibody during phase III trials due to efficacy. |
Immunogen | n/a |
Other Names | Anti-CA9 Recombinant Antibody, Research Grade Girentuximab, Anti-Human CA9 Recombinant Antibody, WX-G250, cG250, Antibody Drug Analogues, Monoclonal Antibody, YR1222, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 916138-87-9 |
Catalog # | YR1222 |
Price | please inquire |
Order / More Info | CA9, Human (Girentuximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |